Atamer, A.Ilhan, N.Kocylgit, Y.Toprak, G.Ozbay, M.Celik, Y.2024-04-242024-04-2420080300-06051473-2300https://doi.org/10.1177/147323000803600108https://hdl.handle.net/11468/1815176th Congress of the European-Atherosclerosis-Society/15th Paavo Nurmi Symposium -- JUN 10-13, 2007 -- Univ Helsinki, Helsinki, FINLANDWe investigated the role of leptin and asymmetric dimethylarginine (ADMA) in uncomplicated hypertension. We also investigated their relationship with insulin resistance and serum levels of several metabolic parameters, including homocysteine, lipoprotein(a) and malondialdehyde (MDA). A total of 34 untreated newly-diagnosed hypertensive patients (seven men and 27 women; mean age, 57.4 +/- 10.1 years) and 38 normotensive healthy subjects (20 men and 18 women; mean age, 55.9 +/- 8.7 years) were studied prospectively. Serum leptin, homocysteine, lipoprotein(a), MDA and insulin resistance (HOMA-IR) were significantly higher in hypertensive patients compared with normotensive subjects. There were no significant differences in ADMA, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 between the two groups. No correlation was found between serum ADMA and leptin levels. Our findings suggest that high serum leptin and homocysteine levels, oxidative stress and insulin resistance may be important risk factors for atherosclerosis among patients with uncomplicated hypertension.eninfo:eu-repo/semantics/openAccessHypertensionLeptinLipoproteinInsulin ResistanceAsymmetric Dimethylarginine (Adma)Malondialdehyde (Mda)Conference Object3615462WOS:0002531717000082-s2.0-391490968771823026810.1177/147323000803600108Q2Q4